Immuron IMRN
NASDAQ IMRN
$0.97 -0.05 (-4.90%)
At close: Oct 21, 2026 · 4:00 PM EDT

Immuron (IMRN) Other Non-Current Assets (2018 - 2023)

Updated

Immuron's Other Non-Current Assets was $14.66 million in fiscal Q4 2023 (quarter ended Jun 30, 2023), down 17.7% from $17.81 million a year earlier.

Analysis

Immuron (IMRN) Other Non-Current Assets (2018 - 2023) Analysis & Trends

At the end of FY2023 (ended Jun 30, 2023), Other Non-Current Assets at Immuron came in at $14.77 million, down 18.2% from FY2022.

  • Other Non-Current Assets shows a five-year compound annual growth rate of 54.1% (FY2018 to FY2023).
  • In earlier fiscal years, Other Non-Current Assets was $18.05 million in FY2022, $1.16 million in FY2020 (-14.0%) and $1.34 million in FY2019 (-20.9%).
  • The fiscal Q4 2023 figure marks the lowest quarterly Other Non-Current Assets since fiscal Q4 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 7.48 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 14.27 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 10.73 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 19.60 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 5.93 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 12.98 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 4.75 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 9.94 Bn
10 Immuron 7.32 Mn -9.83 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 14.52 Mn
Jun 30, 2022 17.11 Mn
Jun 30, 2020 1.18 Mn
Jun 30, 2019 1.30 Mn
Jun 30, 2018 1.60 Mn
API Access

Immuron Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=IMRN&period=max&api_key=YOUR_API_KEY